Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancer

Kosei Matsue, Keitaro Matsuo, Hideaki Fujiwara, Kan Ichi Iwama, Brian Y. Hayama, Shun Ichi Kimura, Masayuki Yamakura, Masami Takeuch

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancer'. Together they form a unique fingerprint.